See more : FGV Holdings Berhad (5222.KL) Income Statement Analysis – Financial Results
Complete financial analysis of Sensus Healthcare, Inc. (SRTS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sensus Healthcare, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
- GD Entertainment & Technology, Inc. (GDET) Income Statement Analysis – Financial Results
- Voltalia SA (VLTSA.PA) Income Statement Analysis – Financial Results
- Seiko Corporation (6286.T) Income Statement Analysis – Financial Results
- Financial Strategies Acquisition Corp. (FXCOW) Income Statement Analysis – Financial Results
- PFA Invest Indeks Mellemlange O (PFIIMO.CO) Income Statement Analysis – Financial Results
Sensus Healthcare, Inc. (SRTS)
About Sensus Healthcare, Inc.
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 24.41M | 44.53M | 27.04M | 9.58M | 27.26M | 26.43M | 20.59M | 14.81M | 10.27M | 5.81M | 10.48M |
Cost of Revenue | 10.35M | 14.90M | 10.05M | 4.33M | 9.71M | 9.52M | 6.79M | 4.97M | 3.70M | 2.05M | 3.60M |
Gross Profit | 14.06M | 29.63M | 16.99M | 5.25M | 17.56M | 16.91M | 13.80M | 9.85M | 6.57M | 3.76M | 6.88M |
Gross Profit Ratio | 57.61% | 66.53% | 62.82% | 54.81% | 64.40% | 63.99% | 67.03% | 66.48% | 64.00% | 64.63% | 65.64% |
Research & Development | 3.68M | 3.46M | 3.44M | 4.16M | 6.42M | 6.26M | 5.49M | 1.82M | 1.47M | 1.58M | 1.33M |
General & Administrative | 5.16M | 5.01M | 4.59M | 3.99M | 4.00M | 4.12M | 3.72M | 3.47M | 1.59M | 1.65M | 1.45M |
Selling & Marketing | 5.61M | 6.33M | 4.84M | 5.34M | 9.10M | 8.53M | 8.31M | 4.92M | 3.74M | 4.21M | 3.97M |
SG&A | 10.76M | 11.34M | 9.43M | 9.33M | 13.11M | 12.66M | 12.03M | 8.38M | 5.33M | 5.86M | 5.42M |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 14.44M | 14.80M | 12.87M | 13.48M | 19.53M | 18.92M | 17.52M | 10.21M | 6.80M | 7.44M | 6.75M |
Cost & Expenses | 24.79M | 29.70M | 22.92M | 17.81M | 29.23M | 28.43M | 24.31M | 15.17M | 10.49M | 9.49M | 10.35M |
Interest Income | 992.00K | 382.00K | 2.00K | 52.56K | 268.29K | 139.28K | 75.81K | 38.54K | 1.78K | 820.00 | 1.25K |
Interest Expense | 0.00 | 2.00K | 1.00K | 14.23K | 0.00 | 156.69K | 68.88K | 21.87K | 17.79K | 20.03K | 20.47K |
Depreciation & Amortization | 461.00K | 315.00K | 613.00K | 721.87K | 545.72K | 658.26K | 387.92K | 337.58K | 315.60K | 272.65K | 265.56K |
EBITDA | 79.00K | 14.83M | 4.73M | -6.10M | -1.15M | -1.21M | -3.25M | 13.00K | 96.12K | -3.41M | 393.65K |
EBITDA Ratio | 0.32% | 34.16% | 15.24% | -100.03% | -6.24% | -7.06% | -17.69% | -2.19% | 0.94% | -58.63% | 3.76% |
Operating Income | -382.00K | 14.83M | 4.12M | -8.23M | -1.97M | -2.01M | -3.72M | -363.12K | -221.26K | -3.68M | 126.84K |
Operating Income Ratio | -1.57% | 33.30% | 15.24% | -85.98% | -7.22% | -7.59% | -18.06% | -2.45% | -2.15% | -63.34% | 1.21% |
Total Other Income/Expenses | 1.03M | 13.16M | -1.00K | 1.40M | 268.29K | -17.41K | 6.93K | 16.67K | -16.01K | -19.21K | -19.21K |
Income Before Tax | 652.00K | 27.99M | 4.12M | -6.84M | -1.70M | -2.02M | -3.71M | -346.45K | -237.27K | -3.70M | 107.63K |
Income Before Tax Ratio | 2.67% | 62.85% | 15.23% | -71.37% | -6.24% | -7.65% | -18.02% | -2.34% | -2.31% | -63.67% | 1.03% |
Income Tax Expense | 167.00K | 3.75M | -613.00K | -2.12M | -545.72K | 139.28K | -312.11K | -299.05K | 1.78K | 820.00 | 1.25K |
Net Income | 485.00K | 24.24M | 4.12M | -4.72M | -1.15M | -2.02M | -3.71M | -346.45K | -237.27K | -3.70M | 107.63K |
Net Income Ratio | 1.99% | 54.44% | 15.23% | -49.24% | -4.23% | -7.65% | -18.02% | -2.34% | -2.31% | -63.67% | 1.03% |
EPS | 0.03 | 1.47 | 0.25 | -0.29 | -0.07 | -0.14 | -0.28 | -0.03 | -0.02 | -0.37 | -0.04 |
EPS Diluted | 0.03 | 1.46 | 0.25 | -0.29 | -0.07 | -0.14 | -0.28 | -0.03 | -0.02 | -0.37 | -0.04 |
Weighted Avg Shares Out | 16.26M | 16.48M | 16.48M | 16.43M | 16.23M | 14.12M | 13.24M | 12.03M | 10.78M | 9.88M | 9.79M |
Weighted Avg Shares Out (Dil) | 16.27M | 16.62M | 16.50M | 16.43M | 16.23M | 14.12M | 13.24M | 12.03M | 10.78M | 9.89M | 9.89M |
Sensus Healthcare: Better Outcomes For Painful Procedures
MDA Breakout Stocks Week 2 - January 2023: High-Frequency Gainers To Give You An Edge
How 2022's Biggest Healthcare Gainers Could Fare In 2023
Sensus Healthcare, Inc. (SRTS) Q3 2022 Earnings Call Transcript
Recent Price Trend in Sensus Healthcare, Inc. (SRTS) is Your Friend, Here's Why
Sensus Healthcare Introduces Silk™ Laser Hair Removal System
Leading Medical Stocks, Including Sensus And Shockwave, Have Grown At Least 36% This Year
Sensus Healthcare to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Medical Device Maker Announces New Patients, Shoots Past Buy Point
5 Stocks With Recent Price Strength to Enrich Your Portfolio
Source: https://incomestatements.info
Category: Stock Reports